Anionic Linear Globular Dendrimer-G2-Ciprofloxacin Nano-Conjugate: Novel Agent against Wilson Disease Cell Model

E-ISSN： 1875-628x|11|7|908-916

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.11, Iss.7, 2014-08, pp. : 908-916

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GLUTATHIONE S-CONJUGATE FORMATION AND METABOLISM IN HepG2 CELLS: A CELL MODEL OF MERCAPTURIC ACID BIOSYNTHESIS

By Rebbeor James F. Wang Wei Clifton Dawn Ballatori Nazzareno

Journal of Toxicology and Environmental Health, Vol. 53, Iss. 8, 1998-04 ,pp. : 651-663

Taylor & Francis Ltd

Access to resources Recommend Favorite

Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo

By Anno Takayuki Higashi Taishi Motoyama Keiichi Hirayama Fumitoshi Uekama Kaneto Arima Hidetoshi

Journal of Drug Targeting, Vol. 20, Iss. 3, 2012-04 ,pp. : 272-280

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic approaches to the treatment of Wilson’s disease

By Brewer George J

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 3, 2006-02 ,pp. : 317-324

Informa Healthcare

Access to resources Recommend Favorite

Degradation of BMS-753493, a novel epothilone folate conjugate anticancer agent

By Gokhale Madhushree Thakur Ajit Rinaldi Frank

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 9, 2013-09 ,pp. : 1315-1327

Informa Healthcare

Access to resources Recommend Favorite

Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α -cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in viv o

By Hayashi Yuya

Journal of Drug Targeting, Vol. 21, Iss. 5, 2013-05 ,pp. : 487-496

Informa Healthcare

Access to resources Recommend Favorite